Transaction in Own Shares
Wells Fargo & Co.
n/a
16:45 20/12/24
Transaction in own shares
Whitbread PLC (Whitbread) announces today it has purchased the following number of its ordinary shares of 76 122/153 pence each through J.P. Morgan Securities plc. Such purchase was effected pursuant to instructions issued by Whitbread on 16 October 2024, as announced on 16 October 2024.
Date of purchase:
| 1 November 2024 |
Aggregate number of ordinary shares purchased:
| 311,733 |
Lowest price paid per share:
| 2,995.0000 |
Highest price paid per share:
| 3,074.0000 |
Average price paid per share:
| 3,046.1093 |
Whitbread intends to cancel the purchased shares.
Since 16 October 2024, Whitbread has purchased 1,231,187 shares at a cost (including dealing and associated costs) of £38,961,819.90.
Following the above transaction, the Company holds 12,454,718 of its ordinary shares in treasury and has 178,212,712 ordinary shares in issue (excluding treasury shares).
Therefore, the total number of voting rights in Whitbread will be 178,212,712 and this figure may be used by shareholders as the denominator when determining whether they are required to notify their interest in, or a change to their interest in, Whitbread under the Financial Conduct Authority's Disclosure Guidance and Transparency Rules.
The table below contains detailed information about the purchases made as part of the buyback programme.
Schedule of Purchases:
Shares purchased: | Whitbread PLC (ISIN: GB00B1KJJ408) |
Date of purchases: | 1 November 2024 |
Investment firm: | J.P. Morgan Securities plc |
Aggregate information:
Venue | Volume-weighted average price | Aggregated volume | Lowest price per share | Highest price per share |
London Stock Exchange | 3,046.1576 | 149,905 | 2,996.0000 | 3,074.0000 |
CHI-X Europe | 3,046.0008 | 49,601 | 2,996.0000 | 3,074.0000 |
BATS Europe | 3,046.0977 | 95,000 | 2,995.0000 | 3,074.0000 |
Aquis Stock Exchange | 3,046.0658 | 17,227 | 2,996.0000 | 3,074.0000 |
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.